Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
Operating Income
Kamada Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kamada Ltd
NASDAQ:KMDA
|
Operating Income
$10.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
11%
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Operating Income
-$6.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Operating Income
-$43m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Operating Income
-$65.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Operating Income
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Operating Income
-₪32.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
See Also
What is Kamada Ltd's Operating Income?
Operating Income
10.1m
USD
Based on the financial report for Dec 31, 2023, Kamada Ltd's Operating Income amounts to 10.1m USD.
What is Kamada Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
11%
Over the last year, the Operating Income growth was 124%. The average annual Operating Income growth rates for Kamada Ltd have been -19% over the past three years , -12% over the past five years , and 11% over the past ten years .